Press Releases
Drug Research
Roche Launches Dual Antigen and Antibody Hepatitis C Diagnostic Test
Rocheโs new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.
Roche launched its Elecsys HCV Duo immunoassay (Elecsys) in July 2022, which is the first available immunoassay...
Press Releases
AES Clean Technology launches OMNI™ Electric Utility Raceway
AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and biopharmaceutical industry, announces the launch of its smart cable management system for cleanrooms โ the AES OMNIโข Electric Utility Raceway.
The OMNIโข Electric Utility Raceway is...
Drug Research
Merck and Orion Announce Global Collaboration for Oncology Drug
Merck, known as MSD outside the United States and Canada, and Orion Corporation are collaborating to develop and commercialize a treatment for metastatic castration-resistant prostate cancer.
Merck, known as MSD outside the United States and Canada, announced a global development...
Press Releases
Tower Cold Chain Secures Further Investment to Supercharge its Success
Pharmaceutical temperature-controlled specialist Tower Cold Chain has secured ยฃ6.75million in investment, to reinforce the business as the leader in robust, reliable, and reusable cold chain solutions, following a period of rapid and sustained growth.
The investment, backed by Investec, comes...
Press Releases
AARDEX® Group and BIOCORP Recruited by Trials@Home – Decentralized Clinical Trial Centre of Excellence
Following the launch of their global collaboration to support medication adherence in different fields last year, Belgium-based AARDEX GROUP, the leader in tools for measuring and managing adherence to medication in clinical trials, and French-based BIOCORP, the leader in...
Press Releases
Grünenthal to buy NebidoTM testosterone treatment from Bayer for €500m
Privately-owned Grรผnenthal estimates the Nebido brand will add about โฌ100 million to its EBITDA in 2023.
Grรผnenthal has agreed to acquire testosterone treatment NebidoTM and its associated brands from Bayer AG, for up to โฌ500 million.
The long-acting injectable treatment for...
Press Releases
Celegence acquires Qdossier to bolster its regulatory consultancy services and solutions for the pharmaceutical industry
Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has announced the acquisition ofย Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Qdossier also provides leading...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















